Michael Santoro

100,000 More Lawsuits In The Offing For Johnson & Johnson (NYSE:JNJ) On Injuries Related To Diabetes Drug And Vaginal Mesh Devices

2019 is the worst year for Johnson & Johnson (NYSE:JNJ). The company is ordered to pay $8 billion in punitive damages by the jury after it failed to warn the young boy over the side effects of an anti-psychoactive drug – Risperdal. According to the filing, Johnson & Johnson has pushed the doctors to prescribe […]